# Tiburio Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tiburio-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.tiburio.com
- Total disclosed funding: $31M
- Latest round: Series A (Jan 3, 2019)
- Investors on record: 4

## About

Tiburio Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for neurological disorders, utilizing a proprietary platform to enhance treatment efficacy and patient outcomes.Tiburio Therapeutics, Inc. specializes in the development of advanced therapeutics aimed at treating neurological conditions. The firm is based in Cambridge, Massachusetts, US. Founded by Imran Babar, the company successfully raised USD 31 mn in Series A funding on January 3, 2019, with major investments from Alexandria Venture Investments, Longitude Capital, Lundbeckfond Ventures, and New Enterprise Associates. The total amount raised by the company stands at USD 31 mn.Tiburio Therapeutics, Inc. is engaged in the development of therapies specifically targeting neurological disorders, leveraging its proprietary technology platform. The company is focused on advancing clinical candidates through rigorous testing to bring new treatment options to market.Revenue for Tiburio Therapeutics, Inc. is derived from the development and potential commercialization of its therapeutic products. The company’s financial model is centered on securing funding through investment rounds and ultimately generating revenue from product sales following successful clinical trials and market entry.Tiburio Therapeutics, Inc. aims to leverage its recent Series A funding of USD 31 mn to accelerate the development of its therapeutic candidates. Plans include expanding into new markets focusing on North America and Europe by 2025, with ongoing clinical trials to validate their product pipeline. The funding will also support the enhancement of their research capabilities and the initiation of new product development projects.

## Funding rounds

- Series A, Jan 3, 2019, $31M — New Enterprise Associates, Alexandria Venture Investments, Longitude Capital, Lundbeckfond Ventures

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Longitude Capital (https://capitalatlas.ai/funds/longitude-capital) — Series A
- Lundbeckfond Ventures (https://capitalatlas.ai/funds/lundbeckfond-ventures) — Series A